iifl-logo
  • testing
  • |

iifl-logo

Marksans Pharma Ltd Cash Flow Statement

249.95
(-1.34%)
Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Marksans Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

124.32

52.72

16.65

11.94

Depreciation

-15.19

-11.64

-12.25

-15

Tax paid

-25.94

-14.82

-4.22

-0.4

Working capital

82.13

-10.16

7.89

46.78

Other operating items

Operating

165.31

16.09

8.06

43.32

Capital expenditure

30.63

44.79

6.22

11.13

Free cash flow

195.94

60.88

14.28

54.45

Equity raised

925.09

814.82

755.6

725.22

Investing

0.27

0

1.78

2.84

Financing

25.08

-56.05

-6.37

32.61

Dividends paid

0

0

2.04

2.04

Net in cash

1,146.39

819.66

767.35

817.18

Marksans Pharma : related Articles

No Record Found

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.